x

Search for a clinical trial

* (*) mandatory field

INSIGHT: An Open-Label, Extension Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of QR-110 in Subjects With Leber's Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene - BE

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Proqr therapeutics b.v.
  • Website
    • Phase : I - II
  • Principal investigator of clinical trial

  • Pr Bart P LEROY
  • Department of Ophthalmology
  • Ghent University Hospital - UZ Gent
  • Corneel Heymanslaan 10
  • 9000 GENT
  • BELGIUM
  • More information
  • Phone  : +32 (0)9 332 23 06
  • Fax  : -
  • Website
Last update: December 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.